Key result
AF catheter ablation safely prevents recurrence at 2 years in hemophilia A without postprocedural anticoagulation.
Case Report (n=1)
No
Atrial fibrillation catheter ablation can be safely and successfully performed in a patient with mild-to-moderate hemophilia A and low stroke risk using factor replacement, lower-intensity intraprocedural heparin, and avoidance of postprocedural anticoagulation.
Supports feasibility of AF ablation in hemophilia A with tailored periprocedural management; leaves open need for prospective data before wider adoption.
Patients with hemophilia present several unique challenges in the management of atrial fibrillation (AF), particularly with regard to the use of anticoagulation and procedural risks of thrombotic events. Here we describe a case of successful AF ablation performed in a patient with hemophilia A.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2015) conducted a case report in Atrial fibrillation and hemophilia A (n=1). Catheter ablation with intraprocedural heparin and factor VIII replacement, without postprocedural anticoagulation was evaluated on Recurrence of atrial fibrillation and bleeding or thromboembolic complications. Catheter ablation for atrial fibrillation was successfully performed in a patient with hemophilia A using intraprocedural heparin and factor VIII replacement without postprocedural anticoagulation, with no AF recurrence or bleeding at 2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: